CLAG-M or FLAG-Ida Chemotherapy
CLAG-M or FLAG-Ida Chemotherapy Followed Immediately by Related/Unrelated Reduced-Intensity Conditioning (RIC) Allogeneic Hematopoietic Cell Transplantation for Adults With Myeloid Malignancies at High Risk of Relapse: A Phase 1 Study
More Information
- Trial Status
- Accepting patients
- Trial Phase
- Phase 1
- Enrollment
- 120 patients (estimated)
- Sponsors
- Fred Hutchinson / University of Washington Cancer Consortium
- Collaborators
- National Cancer Institute (NCI)
- Tags
- Allogeneic Stem Cell Transplant, Chemotherapy, White Blood Cell Stimulant, Radiation Therapy
- Trial Type
- Treatment
- Last Update
- 1 month ago
- SparkCures ID
- 1563
- NCT Identifier
- NCT04375631
Real People. Real Support.
Need help connecting with this clinical trial? We're here to help!
Print a patient-friendly report to share with your patient.
We can help answer any questions and connect you (or your patient) with the study team.
Schedule a time that is convenient and we’ll call you to see how we can help you and your patient.